We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JHG
301
DELISTED
Janus Henderson
JHG
| $21.9M | 0.06% |
1,077,800
+539,200
| +100% | +$13M |
|
302
Teva Pharmaceuticals
TEVA
$36.2B
| $21.8M | 0.06% |
2,700,300
+1,344,100
| +99% | +$11.9M |
|
303
Bio-Rad Laboratories Class A
BIO
$8.47B
| $21.7M | 0.06% |
52,068
+6,900
| +15% | +$3.44M |
|
304
Kornit Digital
KRNT
$713M
| $21.7M | 0.06% |
813,900
+273,100
| +50% | +$7.86M |
|
|
ERF
305
DELISTED
Enerplus Corporation
ERF
| $21.6M | 0.06% |
1,522,385
-442,000
| -23% | -$6.2M |
|
306
Public Service Enterprise Group
PEG
$39.5B
| $21.5M | 0.06% |
382,500
+292,600
| +325% | +$18.8M |
|
307
SM Energy
SM
$7.26B
| $21.3M | 0.06% |
567,102
-46,100
| -8% | -$1.81M |
|
308
Wayfair
W
$12.5B
| $21.2M | 0.06% |
651,400
-526,900
| -45% | -$27.8M |
|
309
Urban Outfitters
URBN
$6.22B
| $21.1M | 0.06% |
1,074,800
+117,100
| +12% | +$2.45M |
|
310
Pentair
PNR
$10.2B
| $20.9M | 0.06% |
513,500
+73,000
| +17% | +$3.39M |
|
311
TripAdvisor
TRIP
$1.66B
| $20.7M | 0.06% |
938,300
+229,100
| +32% | +$5.13M |
|
312
BWX Technologies
BWXT
$16.2B
| $20.7M | 0.06% |
410,400
+89,000
| +28% | +$4.8M |
|
|
ATVI
313
DELISTED
Activision Blizzard
ATVI
| $20.6M | 0.06% |
277,200
+98,572
| +55% | +$7.72M |
|
|
CPRX
314
DELISTED
Catalyst Pharmaceutical
CPRX
| $20.6M | 0.06% |
1,603,492
+526,200
| +49% | +$6.24M |
|
315
DexCom
DXCM
$28.3B
| $20.6M | 0.06% |
255,376
-845,600
| -77% | -$71.6M |
|
316
Toronto Dominion Bank
TD
$198B
| $20.5M | 0.06% |
+334,600
| New | +$21.7M |
|
317
Dentsply Sirona
XRAY
$2.61B
| $20.3M | 0.06% |
717,235
-715,600
| -50% | -$24.5M |
|
318
Prothena Corp
PRTA
$455M
| $20.3M | 0.06% |
335,000
-112,700
| -25% | -$3.56M |
|
319
Bio-Techne
TECH
$11.2B
| $20.3M | 0.06% |
285,968
+197,200
| +222% | +$17M |
|
|
NEWR
320
DELISTED
New Relic, Inc.
NEWR
| $20.3M | 0.06% |
353,400
+23,000
| +7% | +$1.38M |
|
321
Cummins
CMI
$91.3B
| $20.2M | 0.06% |
99,200
-34,300
| -26% | -$7.3M |
|
322
Waters Corp
WAT
$36.4B
| $20.1M | 0.06% |
74,400
-13,700
| -16% | -$4.37M |
|
323
DoorDash
DASH
$80.3B
| $20M | 0.06% |
405,000
+38,400
| +10% | +$2.56M |
|
324
PVH
PVH
$3.87B
| $20M | 0.06% |
446,252
+2,400
| +0.5% | +$143K |
|
325
Imperial Oil
IMO
$60.8B
| $19.9M | 0.06% |
460,045
-44,500
| -9% | -$2.03M |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.